|
1
|
Armstrong EP: Prophylaxis of cervical
cancer and related cervical disease: A review of the
cost-effectiveness of vaccination against oncogenic HPV types. J
Manag Care Pharm. 16:217–230. 2010.PubMed/NCBI
|
|
2
|
Steward BW and Wild CP: World Cancer
Report. World Health Organization; Geneva: 2014
|
|
3
|
Chaturvedi AK: Beyond cervical cancer:
Burden of other HPV-related cancers among men and women. J Adolesc
Health. 46(4 Suppl): S20–S26. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schiffman M, Castle PE, Jeronimo J,
Rodriguez AC and Wacholder S: Human papillomavirus and cervical
cancer. Lancet. 370:890–907. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gadducci A, Barsotti C, Cosio S, Domenici
L and Riccardo Genazzani A: Smoking habit, immune suppression, oral
contraceptive use and hormone replacement therapy use and cervical
carcinogenesis: A review of the literature. Gynecol Endocrinol.
27:597–604. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Uren A, Fallen S, Yuan H, Usubütün A,
Küçükali T, Schlegel R and Toretsky JA: Activation of the canonical
wnt pathway during genital keratinocyte transformation: A model for
cervical cancer progression. Cancer Res. 65:6199–6206. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Duarte I, Santos A, Sousa H, Catarino R,
Pinto D, Matos A, Pereira D, Moutinho J, Canedo P, Machado JC and
Medeiros R: G-308A TNF-alpha polymorphism is associated with an
increased risk of invasive cervical cancer. Biochem Biophys Res
Commun. 334:588–592. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chan D, Yu S, Chiu PM, Yao KM, Liu VW,
Cheung AN and Ngan HY: Over-expression of FOXM1 transcription
factor is associated with cervical cancer progression and
pathogenesis. J Pathol. 215:245–252. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Murphy N, Ring M, Heffron CC, King B,
Killalea AG, Hughes C, Martin CM, McGuinness E, Sheils O and
O'Leary JJ: p16INK4A, CDC6 and MCM5: Predictive biomarkers in
cervical preinvasive neoplasia and cervical cancer. J Clin Pathol.
58:525–534. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Song JY, Lee JK, Lee NW, Jung HH, Kim SH
and Lee KW: Microarray analysis of normal cervix, carcinoma in situ
and invasive cervical cancer: Identification of candidate genes in
pathogenesis of invasion in cervical cancer. Int J Gynecol Cancer.
18:1051–1059. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhai Y, Kuick R, Nan B, Ota I, Weiss SJ,
Trimble CL, Fearon ER and Cho KR: Gene expression analysis of
preinvasive and invasive cervical squamous cell carcinomas
identifies HOXC10 as a key mediator of invasion. Cancer Res.
67:10163–10172. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fujita A, Sato JR, Rodrigues LO, Ferreira
CE and Sogayar MC: Evaluating different methods of microarray data
normalization. BMC bioinformatics. 7:4692006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Smyth GK: Limma: Linear models for
microarray data. Bioinformatics and computational biology solutions
using R and Bioconductor. Springer; pp. 397–420. 2005, View Article : Google Scholar
|
|
14
|
Benjamini Y and Hochberg Y: Controlling
the false discovery rate: a practical and powerful approach to
multiple testing. Journal of the Royal Statistical Society. Series
B (Methodological). 289–300. 1995.
|
|
15
|
Szekely GJ and Rizzo ML: Hierarchical
clustering via joint between-within distances: Extending Ward's
minimum variance method. Journal of Classification. 22:151–183.
2005. View Article : Google Scholar
|
|
16
|
Xie C, Mao X, Huang J, Ding Y, Wu J, Dong
S, Kong L, Gao G, Li CY and Wei L: KOBAS 2.0: A web server for
annotation and identification of enriched pathways and diseases.
Nucleic Acids Res. 39(Web Server Issue): W316–W322. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Szklarczyk D, Franceschini A, Kuhn M,
Simonovic M, Roth A, Minguez P, Doerks T, Stark M, Muller J, Bork
P, et al: The STRING database in 2011: Functional interaction
networks of proteins, globally integrated and scored. Nucleic Acids
Res. 39(Database Issue): D561–D568. 2011. View Article : Google Scholar :
|
|
18
|
Smoot ME, Ono K, Ruscheinski J, Wang PL
and Ideker T: Cytoscape 2.8: New features for data integration and
network visualization. Bioinformatics. 27:431–432. 2011. View Article : Google Scholar :
|
|
19
|
Huang da W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2008. View Article : Google Scholar
|
|
20
|
Evan GI and Vousden KH: Proliferation,
cell cycle and apoptosis in cancer. Nature. 411:342–348. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Catania A, Urban S, Yan E, Hao C, Barron G
and Allalunis-Turner J: Expression and localization of
cyclin-dependent kinase 5 in apoptotic human glioma cells. Neuro
Oncol. 3:89–98. 2001.PubMed/NCBI
|
|
22
|
Kong EH, Kim YJ, Kim YJ, Cho HJ, Yu SN,
Kim KY, Chang JH and Ahn SC: Piplartine induces caspase-mediated
apoptosis in PC-3 human prostate cancer cells. Oncol Rep.
20:785–792. 2008.PubMed/NCBI
|
|
23
|
Bezerra DP, Militão GC, de Castro FO,
Pessoa C, de Moraes MO, Silveira ER, Lima MA, Elmiro FJ and
Costa-Lotufo LV: Piplartine induces inhibition of leukemia cell
proliferation triggering both apoptosis and necrosis pathways.
Toxicology In Vitro. 21:1–8. 2007. View Article : Google Scholar
|
|
24
|
Kim EK and Choi EJ: Pathological roles of
MAPK signaling pathways in human diseases. Biochim Biophys Acta.
1802:396–405. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wagner EF and Nebreda AR: Signal
integration by JNK and p38 MAPK pathways in cancer development. Nat
Rev Cancer. 9:537–549. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kastan MB and Bartek J: Cell-cycle
checkpoints and cancer. Nature. 432:316–323. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hayward DG, Clarke RB, Faragher AJ, Pillai
MR, Hagan IM and Fry AM: The centrosomal kinase Nek2 displays
elevated levels of protein expression in human breast cancer.
Cancer Res. 64:7370–7376. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hayward DG and Fry AM: Nek2 kinase in
chromosome instability and cancer. Cancer Lett. 237:155–166. 2006.
View Article : Google Scholar
|
|
29
|
Chen Y, Lu B, Yang Q, Fearns C, Yates JR
III and Lee JD: Combined integrin phosphoproteomic analyses and
small interfering RNA-based functional screening identify key
regulators for cancer cell adhesion and migration. Cancer Res.
69:3713–3720. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bonte D, Lindvall C, Liu H, Dykema K,
Furge K and Weinreich M: Cdc7-Dbf4 kinase overexpression in
multiple cancers and tumor cell lines is correlated with p53
inactivation. Neoplasia. 10:920–931. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cho-Rok J, Yoo J, Jang YJ, Kim S, Chu IS,
Yeom YI, Choi JY and Im DS: Adenovirus-mediated transfer of siRNA
against PTTG1 inhibits liver cancer cell growth in vitro and in
vivo. Hepatology. 43:1042–1052. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ito T, Shimada Y, Kan T, David S, Cheng Y,
Mori Y, Agarwal R, Paun B, Jin Z, Olaru A, et al: Pituitary
tumor-transforming 1 increases cell motility and promotes lymph
node metastasis in esophageal squamous cell carcinoma. Cancer Res.
68:3214–3224. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Malinowski DP: Multiple biomarkers in
molecular oncology. I. Molecular diagnostics applications in
cervical cancer detection. Expert Rev Mol Diagn. 7:117–131. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu JM, Pan F, Li L, Liu QR, Chen Y, Xiong
XX, Cheng K, Yu SB, Shi Z, Yu AC and Chen XQ: Piperlongumine
selectively kills glioblastoma multiforme cells via reactive oxygen
species accumulation dependent JNK and p38 activation. Biochem
Biophys Res Commun. 437:87–93. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jarvius M, Fryknäs M, D'Arcy P, Sun C,
Rickardson L, Gullbo J, Haglund C, Nygren P, Linder S and Larsson
R: Piperlongumine induces inhibition of the ubiquitin-proteasome
system in cancer cells. Biochem Biophys Res Commun. 431:117–123.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ginzburg S, Golovine KV, Makhov PB, Uzzo
RG, Kutikov A and Kolenko VM: Piperlongumine inhibits NF-κB
activity and attenuates aggressive growth characteristics of
prostate cancer cells. Prostate. 74:177–186. 2014. View Article : Google Scholar :
|
